CAS 928333-30-6

Formel: C17H14N4O2

InChl: InChI=1S/C17H14N4O2/c22-13-5-3-12(4-6-13)15-11-19-17-8-7-16(20-21(15)17)18-10-14-2-1-9-23-14/h1-9,11,22H,10H2,(H,18,20)

InChI Key: OPKXXSDVMPBIOF-UHFFFAOYSA-N

SMILES: C1=COC(=C1)CNC2=NN3C(=NC=C3C4=CC=C(C=C4)O)C=C2

IRAK inhibitor 2

CAS: 928333-30-6

IRAK inhibitor 2

Formel: C₁₇H₁₄N₄O₂

Reinheit: 99.5%

Molekulargewicht: 306.32

Ref: 54-BUP08187

IRAK inhibitor 2

CAS: 928333-30-6

IRAK inhibitor 2 (IRAK-IN-2) is a potent inhibitor of interleukin 1 receptor-associated kinase 4 (IRAK-4) for the study of inflammation-related diseases.

Formel: C₁₇H₁₄N₄O₂

Reinheit: 98.27% - 99.58%

Farbe und Form: Solid

Molekulargewicht: 306.3187

Ref: TM-T7368

4-(6-((Furan-2-ylmethyl)amino)imidazo[1,2-b]pyridazin-3-yl)phenol

CAS: 928333-30-6

Formel: C₁₇H₁₄N₄O₂

Molekulargewicht: 306.3187

Ref: IN-DA00GU3T

4-(6-((Furan-2-ylmethyl)amino)imidazo[1,2-b]pyridazin-3-yl)phenol

CAS: 928333-30-6

4-(6-((Furan-2-ylmethyl)amino)imidazo[1,2-b]pyridazin-3-yl)phenol

Formel: C₁₇H₁₄N₄O₂

Reinheit: 98%

Molekulargewicht: 306.32

Ref: IN-DG631024

IRAK inhibitor 2

CAS: 928333-30-6

IRAK inhibitor 2 is a kinase inhibitor that is used for the treatment of cancer. It works by inhibiting the activity of protein kinases, which regulate the proliferation and survival of cells. IRAK inhibitor 2 has been shown to be effective against cancer-related genes and has an effective dose on post-transcriptional regulation. The drug also normalizes gene expression in tumor cells, which may be due to its inhibition of protein kinases. IRAK inhibitor 2 is currently being researched as a potential therapy for cancers such as melanoma and pancreatic cancer.

Formel: C₁₇H₁₄N₄O₂

Reinheit: Min. 95%

Molekulargewicht: 306.32 g/mol

Ref: 3D-DMB33330